Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia Curbs GMP Inspections As Coronavirus Bites

Regulator Also Updates On Shortage And Vaccine Actions

Executive Summary

The Australian drugs and devices regulator says that international travel curbs relating to the COVID-19 outbreak have forced it to cut back on its inspections of overseas drug manufacturers. It is also looking out for potential drug shortages and will give the “highest priority” to any new drugs and vaccines that are developed for the virus. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS141859

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel